Will be very interesting to see how the Japan currency play impacts their Neuro division as Japan is, by far, their largest market. Add to that, by paying $150M for a flow diverter business, they've essentially just admitted that flow diverters are impacting their coil volumes. They also had to make an acquisition in order to get into the retrieval business. So, basically no internal product development taking place, pricing pressure in their largest market, and cannibalization of their coil volumes. Not good.